gliclazide has been researched along with Allergic Encephalomyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basak Turkmen, N; Ciftci, O; Kamisli, S; Ozcan, C; Taslidere, A | 1 |
| Cai, W; Han, J; Hao, L; Huang, R; Jin, M; Wang, B; Wang, Y; Xiao, Y; Xu, J; Zhang, Y; Zhou, J | 1 |
2 other study(ies) available for gliclazide and Allergic Encephalomyelitis
| Article | Year |
|---|---|
The beneficial effects of 18β-glycyrrhetinic acid on the experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mouse model.
Topics: Animals; Brain; Caspase 3; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Female; Glycyrrhetinic Acid; Lipid Peroxidation; Mice; Oxidative Stress | 2018 |
18β-glycyrrhetinic acid suppresses experimental autoimmune encephalomyelitis through inhibition of microglia activation and promotion of remyelination.
Topics: Animals; Astrocytes; Brain-Derived Neurotrophic Factor; Central Nervous System; Chemokines; Encephalomyelitis, Autoimmune, Experimental; Glycyrrhetinic Acid; Inflammation; MAP Kinase Signaling System; Mice, Inbred C57BL; Microglia; Myelin Sheath; T-Lymphocytes | 2015 |